This study investigates the differences of Eosinophil Cationic Protein, Tumor Necrosis Factor-alpha and Anti-BP180-NC16A IgG levels of blister fluids in Bullous Pemphigoid patients which appeared before and under treatment subsequently. These molecules will also be measured in blood serum before and under treatment. Changes of titers in serum and differences between blister fluids will be compared to observe whether correlation exists between them. These measures will also be compared between groups of responders and non-responders to the first-line treatment options to analyze correlation with treatment success.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Titers of Eosinophil Cationic Protein in blister fluid and blood serum
Timeframe: 14 Days
Titers of Tumor Necrosis Factor-alpha in blister fluid and blood serum
Timeframe: 14 Days
Titers of Anti-BP180-NC18A IgG in blister fluid and blood serum
Timeframe: 14 Days